Abstract
Autologous stem cell-based therapy offers many advantages over other nonsurgical treatments of peripheral arterial disease. Transplant stem cells are a renewable source of multiple cytokines and growth factors. Autologous adult stem cells are not rejected and do not form teratomas. Early preliminary results indicate that adult stem cell therapy is safe and effective in patients with critical limb ischemia.
Original language | English (US) |
---|---|
Pages (from-to) | 45-47 |
Number of pages | 3 |
Journal | Perspectives in vascular surgery and endovascular therapy |
Volume | 20 |
Issue number | 1 |
DOIs | |
State | Published - 2008 |
Keywords
- Critical limb ischemia
- Peripheral arterial disease
- Revascularization
- Stem cell therapy
ASJC Scopus subject areas
- Surgery
- Cardiology and Cardiovascular Medicine